ROLE OF NEUROMODULATION IN MIGRAINE
The RELIEV-CM2 clinical study will investigate the first-ever, head located implantable neuromodulation devicedesigned to treat Chronic Migraine.
The RELIEV-CM2 clinical study will investigate the first-ever, head located implantable neuromodulation devicedesigned to treat Chronic Migraine.
Where Pain Medicine, Science and Business Intersect Loews Vanderbilt Hotel, Nashville, TN